Main
Portfolio Index > 2006 Genetic
Index > MOLECULAR PHARMA
NIDA Genetics Molecular Pharma Portfolio Listing A - Z
| |
|
 |
| ABOOD, MARY E |
|
| |
5R01DA009978-10 |
| |
|
| ANASTASIO, NOELLE C |
|
| |
1F31DA022824-01 |
| |
|
| ANG, ROSALIND L |
|
| |
1F31DA020308-01A1 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| EDWARDS, ROBERT H |
|
| |
2P01DA010154-11A1 |
| |
|
| ELMER, GREGORY I |
|
| |
5R01DA015087-03 |

|
| |
|
 |
| FRIEDMAN, THEODORE C |
|
| |
5R01DA014659-05 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| ITZHAK, YOSSEF |
|
| |
5R01DA019107-03 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| OSWALD, ROBERT E |
|
| |
5R01DA011643-09 |

|
| |
|
 |

|
| |
|
| |

|
| |
|
 |

|
| |
|
 |
| SANDERS-BUSH, ELAINE |
Hallucinogens
and Serotonin Signal Transduction |
| |
5R01DA005181-17 |
| |
|
SCHILTZ, CRAIG A |
Molecular
Basis of Addiction: Conditioning and Relapse |
| |
5F30DA016503-04 |
| |
|
| SHARP, BURT M |
Interaction
Between Nicotine and Stress |
| |
5R01DA003977-22 |
| |
|
| SIGGINS, GEORGE R |
Morphine
Like Brain Peptides-Cellular Neurobiology |
| |
5R01DA003665-23 |
| |
|
| SIMEN, ARTHUR A |
Epigenetic
Factors in Stress-enhanced Acquisition of Cocaine Self-Administration. |
| |
1R03DA022251-01 |
| |
|
| SMITH, DESMOND J |
Voxelation:
a new method for 3D gene expression analysis |
| |
3R01DA015802-05S1 |
| |
|
| SMITH, DESMOND J |
Voxelation:
a new method for 3D gene expression analysis |
| |
5R01DA015802-05 |
| |
|
| SORKIN, ALEXANDER D |
Dopamine
Transporter Regulation by Endocytosis |
| |
2R01DA014204-05A1 |
| |
|
| STELLA, NEPHI |
Novel
Monoacylglycerol Lipase |
| |
1R21DA022469-01 |
| |
|
| STOWERS, RONALD S |
Genetic
Dissection of Synaptic Transmission |
| |
5K01DA019458-02 |
| |
|
| SURRATT, CHRISTOPHER K |
Dopamine
Transporter Structure-Function Studies |
| |
3R15DA016604-01S2 |

|
| |
|
 |
| THOMAS, DAVID L |
|
| |
5R01DA013806-07 |
| |
|
| TOLL, LAWRENCE R |
|
| |
1R01DA020811-01 |
| |
|
| TURRIGIANO, GINA G |
|
| |
5R01DA016455-05 |
|
| |
|
| |
|
 |
No Names at this time.

|
| |
|
 |
| VAUGHAN, ROXANNE A |
|
| |
5R01DA013147-07 |
| |
|
| VON ZASTROW, MARK E |
|
| |
2R01DA012864-06 |
| |
|
| VORTHERMS, TIMOTHY A |
|
| |
1F32DA022188-01 |

|
| |
|
 |
| WALKER, BRUCE D |
Harvard
University Center for AIDS Research |
| |
5P30AI060354-03 |
| |
|
| WEINSHENKER, DAVID |
Mechanism
of Disulfiram-Induced Cocaine Abstinence |
| |
1R01DA017963-01A2 |
| |
|
| WEINSTEIN, HAREL |
MOLECULAR
DETERMINANTS FOR THE ACTION OF HALLUCINOGENS |
| |
5K05DA000060-26 |
| |
|
| WEINSTEIN, HAREL |
Structure
and Function of Neurotransmitter Transporters |
| |
5P01DA012408-08 |
| |
|
| WEINSTEIN, HAREL |
HALLUCINOGENS & 5-HT2A
RECEPTORS: MECHANISMS AND EFFECTS |
| |
3P01DA012923-05S1 |
| |
|
| WHISTLER, JENNIFER L |
G
Protein Coupled Receptor Trafficking and Opiate Drugs |
| |
5R01DA015232-04 |
| |
|
| WHITEAKER, PAUL |
Immunochemical
Protocols for Nicotinic Receptors |
| |
5R21DA019655-02 |
| |
|
| WINZER-SERHAN, URSULA H |
Nicotinic
Modulation of Hippocampal Development |
| |
5R01DA016487-03 |
| |
|
| WOLF, MARINA E |
Glutamate
and psychostimulant-induced neuroadaptations |
| |
5K02DA000453-07 |
| |
|
| WOLF, MARINA E |
Dopamine
and Glutamate Receptor Interactions |
| |
5R37DA015835-04 |
| |
|
| WOODS, JAMES H |
Development
of Esterases for the Treatment of Cocaine Overdose and Abuse |
| |
1R01DA021416-01 |

|
| |
|
 |
No Names at this time.

|
| |
|
 |

|
| |
|
 |

|
| |
Return to top |
|
|